Oleg Nodelman
Founder + Portfolio Manager
Oleg Nodelman is the Founder and Portfolio Manager of EcoR1 Capital LLC, a biotech-focused investment advisory firm established in 2013, which invests in companies at all stages of research and development. With over twenty years of experience in biotech investing, Mr. Nodelman has expertise in all aspects of investment management and deep roots in the biotech and scientific communities. Before founding EcoR1, Mr. Nodelman was a portfolio manager at BVF Partners, one of the first hedge funds dedicated to investing in the biotechnology sector. He currently serves as a Board Member for three publicly traded companies: Prothena Biosciences (NASDAQ: PRTA), a clinical-stage neuroscience company, AnaptysBio (NASDAQ: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics applicable to inflammatory and autoimmune diseases, and Galapagos (Euronext & NASDAQ: GLPG), a clinical-stage biotechnology company focused on small molecules, CAR-T therapies, and biologics in oncology and immunology. Mr. Nodelman has a Bachelor of Science in Foreign Service with a concentration in Science and Technology from Georgetown University.
Levi Nodelman
Consigliere
Leviathan (Levi) Sunflower Nodelman is a Portuguese Water Dog and has been a member of the EcoR1 team since 2018. He is a triathlete that spends time between Montana and San Francisco and is active on the neighborhood watch, the plastic bag patrol and sometimes works as a ventriloquist. He was born at Aviator Kennels and has a degree in basic obedience from Puppy Prep as well as an advanced degree from the SPCA.
